Cargando…

Mechanisims of asthma and allergic disease – 1066. Ceruloplasmin oxidase activity in allergic asthma and allergic rhinitis

Detalles Bibliográficos
Autores principales:	Yalcin, Arzu Didem, Gumuslu, Saadet, Genc, Gizem, Bisgin, Atil, Yildiz, Mustafa, Kargi, Aysegul, Gorczynski, Reginald M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	World Allergy Organization 2013
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643626/ http://dx.doi.org/10.1186/1939-4551-6-S1-P64

Ejemplares similares

Mechanisims of asthma and allergic disease - 1088. Increased serum strail level in newly diagnosed stave-iv lung adenocarcinoma but not sqamous cell carcinoma, is correlated with age and smoking
por: Kargi, Aysegul, et al.
Publicado: (2013)

278 Total Antioxidant Capacity, Hydrogen Peroxide, Malondialdehyde and Total Nitric Oxide Concentrations in Patients With Severe Persistent Allergic Asthma: Its Relation to Omalizumab Treatment
por: Yalcin, Arzu Didem, et al.
Publicado: (2012)

Serum-soluble TRAIL levels in patients with severe persistent allergic asthma: Its relation to omalizumab treatment
por: Yalcin, Arzu Didem, et al.
Publicado: (2012)

277 Serum Soluble Trail Levels in Patients With Severe Persistent Allergic Asthma: Its Relation to Omalizumab Treatment
por: Yalcin, Arzu Didem, et al.
Publicado: (2012)

233 The Evaluation of Allergen Sensitivity in Allergic Rhinoconjunctivitis and Allergic Asthma Patients in Antalya, Turkey
por: Yalcin, Arzu Didem, et al.
Publicado: (2012)

Pollen aero allergens and the climate in mediterranean region and allergen sensitivity in allergic rhinoconjunctivitis and allergic asthma patients
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

Soluble trail as a marker of efficacy of allergen-specific immunotherapy in patients with allergic rhinoconjunctivitis
por: Yalcin, Arzu Didem, et al.
Publicado: (2012)

Health outcomes, education, healthcare delivery and quality – 3052. IL-17, IL-18, TGF-beta and GMCSF levels in patients with allergic asthma: Its relation to omalizumab treatment
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

IL-8, IL-10, TGF-β, and GCSF Levels Were Increased in Severe Persistent Allergic Asthma Patients with the Anti-IgE Treatment
por: Yalcin, Arzu D., et al.
Publicado: (2012)

270 Clinical Experience in Allergic Asthma Patients: Omalizumab with Immunotherapy
por: Yalcin, Arzu Didem, et al.
Publicado: (2012)

Environmental and occupational respiratory diseases – 1062. The climate and aero allergens in Mediterranean region and allergen sensitivity in allergic rhinoconjuctivitis and allergic asthma patients
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

Mechanisims of asthma and allergic disease – 1076. Identification of genes related to seasonal allergic rhinitis by microarray analysis
por: Imoto, Yoshimasa, et al.
Publicado: (2013)

Health outcomes, education, healthcare delivery and quality – 3038: The relation of sTRAIL levels and quality of life in omalizumab using severe persistent allergic asthma patients
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

Mechanisims of asthma and allergic disease – 1084. Localization and up-regulation of CysLT2 receptorin perennial allergic rhinitis
por: Shirasaki, Hideaki, et al.
Publicado: (2013)

Mechanisims of asthma and allergic disease – 1074. Prebiotics in infants for prevention of allergic disease and hypersensitiivity
por: Sinn, John
Publicado: (2013)

Mechanisims of asthma and allergic disease – 1070. Genetic mechanisms of immune imbalance in allergic inflamation
por: Ziyadullaev, Uktam
Publicado: (2013)

Mechanisims of asthma and allergic disease – 1075. Probiotics in infants for prevention of allergic disease and food hypersensitivity
por: Sinn, John
Publicado: (2013)

Environmental and occupational respiratory diseases – 1039. Clinical course and side effects of anti-IgE monoclonal antibody in patients with severe persistent asthma
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

Mechanisims of asthma and allergic disease – 1072: CD48: a novel biomarker for asthma?
por: Minai-Fleminger, Yael, et al.
Publicado: (2013)

Mechanisims of asthma and allergic disease – 1091. Eosinophilia nasal impact over the lunch function tests in patients with moderate to severe persisten allergic rhinitis
por: Calva, Maricruz, et al.
Publicado: (2013)

Is suicidal ideation associated with allergic asthma and allergic rhinitis?
por: Bedolla-Barajas, Martín, et al.
Publicado: (2018)

Investigation of Allergic Sensitizations in Children With Allergic Rhinitis and/or Asthma
por: Dai, Lingman, et al.
Publicado: (2022)

Mechanisims of asthma and allergic disease – 1089. The effect of the gender of the fetus on the control of asthma during pregnancy
por: Zidan, Mohamed Helmi, et al.
Publicado: (2013)

Mechanisims of asthma and allergic disease – 1079. Evidence of platelet activation in asthmatic patients
por: Jin, Hyun Jung, et al.
Publicado: (2013)

The effects of climate and aero allergens changes in allergic rhinoconjunctivitis and allergic asthma patients in mediterranean region between 2011 and 2012
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

Self-assessment of Allergic Rhinitis and Asthma (SACRA) Questionnaire-based Allergic Rhinitis Treatment Improves Asthma Control in Asthmatic Patients with Allergic Rhinitis
por: Yasuo, Masanori, et al.
Publicado: (2017)

Anti-allergic effect of luteolin in mice with allergic asthma and rhinitis
por: Jang, Tae Young, et al.
Publicado: (2017)

The effect of Co-Q10 on allergic rhinitis and allergic asthma
por: Du, Qixue, et al.
Publicado: (2021)

Mechanisims of asthma and allergic disease – 1081. Resolvin inhibits the cryopyrin/nalp3 inflammasome
por: Ruan, Cox, et al.
Publicado: (2013)

Allergic rhinitis: evidence for impact on asthma
por: Thomas, Mike
Publicado: (2006)

Clinical Characteristics of Allergic Rhinitis According to Allergic Rhinitis and Its Impact on Asthma Guidelines
por: Lee, Chul Hee, et al.
Publicado: (2008)

Immunotherapy – 2071. Strail levels decreased after allergen-subcutaneous specific immunotherapy
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

Mechanisims of asthma and allergic disease – 1086. Bacteria-derived extracellular vesicles as an important causative agent for asthma and COPD
por: Jee, Young-Koo, et al.
Publicado: (2013)

Mechanisims of asthma and allergic disease – 1077. Differential expression and roles oF MMP-2, MMP-9, MMP-13, TIMP-1, and TIMP-2 in allergic rhinitis
por: Mori, Sachiko, et al.
Publicado: (2013)

Vitamin D serum levels in allergic rhinitis
por: Kose, Sukran, et al.
Publicado: (2015)

Mechanisims of asthma and allergic disease – 1065. Association between level of serum IL 31 and IL 33 and pruritus in Malaysian allergic patients
por: Mohd Ashari, Noor Suryani, et al.
Publicado: (2013)

Asthma and allergic rhinitis: Linked in treatment and outcomes
por: Price, David
Publicado: (2010)

Determinants of Allergic Rhinitis in Young Children with Asthma
por: Moussu, Lise, et al.
Publicado: (2014)

Severity of allergic rhinitis and asthma development in children
por: Di Cara, Giuseppe, et al.
Publicado: (2015)

Allergic rhinitis: the “Ghost Diagnosis” in patients with asthma
por: Egan, Maureen, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_us48u0hat63838m44dhbpum7gm